2 recruiting, 1 unknown. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Amoxicillin 250 MG: new trials by email Literature Review of Amoxicillin 250 MG trials Research Report on Amoxicillin 250 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT) Ceftriaxone 1000 MG, Clarithromycin 500mg, Metronidazole 500 mg - Preterm Premature Rupture of Membrane, Pregnancy, High Risk | Phase 4 | Recruiting | Ohio State University | 56 | 2024-07-18 | 2026-01-27 |
| Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge Amoxicillin 250 MG, Placebo, Amoxicillin 62.5mg - Penicillin Allergy | Phase 3 | Recruiting | James Tarbox, MD | 380 | 2024-02-03 | 2025-05-01 |
| Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients Amoxicillin 250 MG - Penicillin Allergy | Not applicable | Unknown | Saskatchewan Health Authority - Regina Area | 50 | 2023-12-01 | 2023-04-13 |
Drug Hypersensitivity (2) · Chorioamnionitis (1) · Hypersensitivity (1) · Premature Birth (1) · Preterm Premature Rupture of the Membranes (1)
James Tarbox, MD (1) · Ohio State University (1) · Saskatchewan Health Authority - Regina Area (1)
United States (2)
Andrea Fong, MD, FRCPC (1) · James A Tarbox, MD (1) · Kartik K Venkatesh, MD, PhD (1) · Marissa Berry, MD (1)
PMID 24188976, PMID 24565482, PMID 26110680, PMID 27043788, PMID 28341170, PMID 28483317, PMID 29425903, PMID 29802906, PMID 29803713, PMID 29883754, PMID 30903298